Drug: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
Find trials that include: Any drugs shown
Trial Status: Active
1.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 13 to 15 at first immunization Sponsor: Other Protocol IDs: HPV CSP01, NCT00956553
|
|
2.
|
Phase: Phase IV Type: Prevention Status: Approved-not yet active Age: 13 to 15 Sponsor: Other Protocol IDs: 37207, NCT01021904
|
|
3.
|
Phase: Phase IV Type: Prevention Status: Active Age: 15 to 25 Sponsor: Pharmaceutical / Industry Protocol IDs: 109823, NCT01031069
|
|
4.
|
Phase: Phase IV Type: Prevention Status: Active Age: 11 to 17 Sponsor: Other Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHKT-RLP/2011, 2011-002667-14, NCT01375868
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 27 and over Sponsor: NIAID Protocol IDs: A5298, 11798, NCT01461096
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 13 to 26 Sponsor: NCI, Other Protocol IDs: CDR0000685816, AMC-072, NCT01209325
|
|
8.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention Status: Active Age: 9 to 26 Sponsor: NCI, Other Protocol IDs: 11034, NCI-2011-03654, 1R01CA166559, Merck-IISP#40083, NCT01492582
|
|
9.
|
Phase: No phase specified Type: Prevention Status: Active Age: 18 to 26 Sponsor: Other Protocol IDs: AAAD1877, NCT00730704
|
|
10.
|
Phase: No phase specified Type: Prevention Status: Active Age: 9 to 15 Sponsor: Other Protocol IDs: Pro00014388, CDC#U36/CCU319276 CFDA 93.283, NCT00862810
|
|
11.
|
Phase: No phase specified Type: Health services research, Prevention Status: Active Age: 9 to 13 Sponsor: Other Protocol IDs: 36448, NCT01096134
|
|
12.
|
Phase: No phase specified Type: Health services research, Prevention, Screening Status: Active Age: 18 to 26 Sponsor: Other Protocol IDs: 33249, NCT01133509
|
|
13.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 26 Sponsor: Other Protocol IDs: 2011/02_Medicine, NCT01298869
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 18 to 26 Sponsor: NCI Protocol IDs: 2010C0114, P50CA105632, OSU-10096, NCT01299714
|
|
15.
|
Phase: No phase specified Type: Natural history/Epidemiology Status: Approved-not yet active Age: 9 to 45 Sponsor: Other Protocol IDs: V501-030-1, NCT01427777
|